• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用PhaSeal(®)封闭系统转移装置制备抗肿瘤药物所实现的成本节约。

Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents.

作者信息

Edwards Michael S, Solimando Dominic A, Grollman Franklin R, Pang Janet L, Chasick Ashley H, Hightman Charlene M, Johnson Anthony D, Mickens Maxine G, Preston Lorenzo M

机构信息

Hematology-Oncology Pharmacy Service, Department of Pharmacy, Walter Reed National Military Medical Center, Bethesda, MD, USA.

出版信息

J Oncol Pharm Pract. 2013 Dec;19(4):338-47. doi: 10.1177/1078155213499387. Epub 2013 Aug 23.

DOI:10.1177/1078155213499387
PMID:23975556
Abstract

PURPOSE

Medication cost is a major factor associated with increasing health care costs in the United States. Expenditures for prescription drugs in 2013 are estimated to be $283.7 billion. Closed system transfer devices are widely used for preparation of hazardous drugs. Reports indicate the Phaseal(®) closed system transfer device maintains sterility in vials for 7 days, suggesting the unused portion of single-use vials could be salvaged. This study was done to determine whether using a closed system transfer device to extend the beyond-use date of single-use vials of antineoplastic medications would result in a measurable cost saving.

METHODS

A list of 25 drugs available in single-use vials, with a chemical stability of at least 48 hours, was compiled. Use of these agents was recorded during a 50-day period in April through June 2012. Use from a total of 296 vials of 21 antineoplastic agents was recorded. After allowing for the initial use of each vial, the mean potential percentage of drug waste was calculated to be 57.03%.

RESULTS

Actual savings during the study period was $96,348.70. The pharmacy avoided nearly half of the potential waste and saved a mean of 29% of each vial. The cost-saving during the study period represents a $703,047.67 annual saving; which more than offsets the $106,556.55 the pharmacy spent for the Phaseal(®) system in 2012.

CONCLUSION

In addition to being a protective measure to reduce exposure to hazardous agents, use of the Phaseal(®) system results in a reduction in drug waste, and a noticeable cost saving for antineoplastic agents.

摘要

目的

药物成本是美国医疗保健成本上升的一个主要因素。2013年处方药支出估计为2837亿美元。封闭系统转移装置广泛用于危险药物的配制。报告表明,Phaseal(®)封闭系统转移装置可使小瓶保持无菌7天,这表明一次性小瓶中未使用的部分可以挽救。本研究旨在确定使用封闭系统转移装置延长一次性抗肿瘤药物小瓶的使用期限是否会带来可衡量的成本节约。

方法

编制了一份25种可用于一次性小瓶的药物清单,其化学稳定性至少为48小时。在2012年4月至6月的50天内记录了这些药物的使用情况。记录了总共296瓶21种抗肿瘤药物的使用情况。在考虑每个小瓶的初始使用后,计算出药物浪费的平均潜在百分比为57.03%。

结果

研究期间实际节省了96348.70美元。药房避免了近一半的潜在浪费,平均每瓶节省了29%。研究期间的成本节约相当于每年节省703047.67美元;这足以抵消药房2012年为Phaseal(®)系统花费的106556.55美元。

结论

除了作为减少接触危险制剂的保护措施外,使用Phaseal(®)系统还可减少药物浪费,并为抗肿瘤药物节省可观的成本。

相似文献

1
Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents.使用PhaSeal(®)封闭系统转移装置制备抗肿瘤药物所实现的成本节约。
J Oncol Pharm Pract. 2013 Dec;19(4):338-47. doi: 10.1177/1078155213499387. Epub 2013 Aug 23.
2
Safe Cytotoxic Drug Preparation Using Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal).使用封闭系统转移装置进行细胞毒性药物的安全制备:一种新型装置(Vialshield/Texium)与参考装置(Phaseal)的技术和实际评估
Int J Pharm Compd. 2016 Mar-Apr;20(2):148-54.
3
Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital.马来西亚一家政府资助医院使用封闭系统转移装置(CSTD)进行抗肿瘤药物配制的成本分析
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4951-4957. doi: 10.22034/APJCP.2016.17.11.4951.
4
Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.使用封闭系统药物转移装置减少工作场所细胞毒性表面污染。
J Oncol Pharm Pract. 2010 Mar;16(1):19-25. doi: 10.1177/1078155209352543. Epub 2009 Dec 4.
5
The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparation.PhaSeal®系统:其使用对工作场所污染及化疗准备时间的影响。
J Oncol Pharm Pract. 2012 Mar;18(1):37-45. doi: 10.1177/1078155211401454. Epub 2011 Mar 21.
6
Use of a closed-system drug transfer device (PhaSeal) and impact on preparation time.
Int J Pharm Compd. 2012 Sep-Oct;16(5):431-3.
7
[Verification of reduction in preparation time and cost of cyclophosphamide when using the closed-system drug transfer device].[使用密闭式药物转移装置时环磷酰胺制备时间和成本降低的验证]
Gan To Kagaku Ryoho. 2014 May;41(5):611-5.
8
Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.使用封闭式药物转移装置可消除抗肿瘤药物的表面污染。
J Oncol Pharm Pract. 2013 Jun;19(2):99-104. doi: 10.1177/1078155212468367. Epub 2013 Jan 4.
9
[Pressure Compatibility Test of Closed System Drug Transfer Devices for 71 Anticancer Drugs].[71种抗癌药物的密闭式药物转移装置压力兼容性测试]
Yakugaku Zasshi. 2021;141(1):143-150. doi: 10.1248/yakushi.20-00188.
10
Syringe plunger contamination by hazardous drugs: a comparative study.危险药物对注射器活塞的污染:一项对比研究。
J Oncol Pharm Pract. 2014 Oct;20(5):381-5. doi: 10.1177/1078155214526428. Epub 2014 Mar 5.

引用本文的文献

1
Optimising oncology drug expenditure in Ireland.优化爱尔兰的肿瘤药物支出。
Ir J Med Sci. 2024 Aug;193(4):1735-1747. doi: 10.1007/s11845-024-03672-y. Epub 2024 Apr 3.
2
Evaluating drug stability and sterility in single-dose vials when accessed with a closed system transfer device.使用密闭系统转移装置开启单剂量瓶时对药物稳定性和无菌性进行评估。
SAGE Open Med. 2024 Feb 26;12:20503121241230449. doi: 10.1177/20503121241230449. eCollection 2024.
3
Cost analysis of implementing a vial-sharing strategy for chemotherapy drugs using intelligent dispensing robots in a tertiary Chinese hospital in Sichuan.
在中国四川的一家三级医院中使用智能配药机器人实施化疗药物小瓶共享策略的成本分析。
Front Public Health. 2022 Sep 21;10:936686. doi: 10.3389/fpubh.2022.936686. eCollection 2022.
4
Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners.封闭式输液器在肿瘤生物制剂治疗中的应用:加拿大医护人员的调查。
J Oncol Pharm Pract. 2022 Jun;28(4):805-815. doi: 10.1177/10781552211010928. Epub 2021 May 18.
5
Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices.研究综述:考察用于密闭式药物传输装置制备的小瓶中微生物污染情况。
Eur J Hosp Pharm. 2021 Mar;28(2):65-70. doi: 10.1136/ejhpharm-2019-001913. Epub 2019 May 15.
6
Advanced Medical Devices for Preparation and Administration of Chemotherapeutic Agents: Results from a Multi-Dimensional Evaluation.用于化疗药物制备和给药的先进医疗设备:多维评估结果
Clinicoecon Outcomes Res. 2020 Dec 1;12:711-722. doi: 10.2147/CEOR.S267283. eCollection 2020.
7
Review of economic data on closed system transfer drug for preparation and administration of hazardous drugs.密闭式药物传输系统经济数据回顾:用于危险药物的准备和管理
Eur J Hosp Pharm. 2020 Nov;27(6):361-366. doi: 10.1136/ejhpharm-2018-001775. Epub 2019 Feb 22.
8
A Cost Saving and Waste Minimization Study About Handling of the Antineoplastic Agents.一项关于抗肿瘤药物处理的成本节约与废物最小化研究。
Turk J Pharm Sci. 2017 Dec;14(3):304-310. doi: 10.4274/tjps.25238. Epub 2017 Nov 20.
9
[Not Available].[无可用内容]
Can J Hosp Pharm. 2020 Jan-Feb;73(1):27-36. Epub 2020 Feb 1.
10
Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.封闭系统药物转移装置加危险药物安全操作与仅进行安全操作相比,对减少医护人员接触输注性危险药物的影响
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD012860. doi: 10.1002/14651858.CD012860.pub2.